Eric AlonzoScientist, Cellular Analytics at Bluebird Bio
Dr. Alonzo, currently leads the CAR T cell analytics team within the Pharmaceutical Sciences Division at bluebird bio. His primary role is developing the characterization strategy for all oncology programs at bluebird bio. Prior to bluebird bio, Dr. Alonzo lead efforts developing T cell-based therapies at Agenus (Lexington, MA), and previous to his work at Agenus, he a postdoctoral fellow at Massachusetts General Hospital and Harvard Medical School working on a mouse model of T cell acute lymphoblastic leukemia. Dr. Alonzo received his PhD from the Cancer Biology Program at Memorial Sloan-Kettering Cancer Center.